Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume 59, Issue 11, Pages 6834-6856
Publisher
Springer Science and Business Media LLC
Online
2022-09-01
DOI
10.1007/s12035-022-03005-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
- (2021) Manuel Grundmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Emerging Role of Polyphenols in the Management of Type 2 Diabetes
- (2021) Yao Wang et al. MOLECULES
- Protective properties of GLP‐1 and associated peptide hormones in neurodegenerative disorders
- (2021) Christian Hölscher BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
- (2021) Lu-Lu Bu et al. Neurotherapeutics
- Diffusion kurtosis imaging detects the time‐dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease
- (2021) Amit Khairnar et al. JOURNAL OF NEUROCHEMISTRY
- Impaired brain insulin signalling in Parkinson's disease
- (2021) Fares Bassil et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies
- (2021) Carolina Vaccari et al. PLoS One
- Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
- (2021) Ameng Shi et al. Frontiers in Pharmacology
- Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson’s disease
- (2021) Bing Cao et al. METABOLIC BRAIN DISEASE
- Neuropathological evidence of body-first vs. brain-first Lewy body disease
- (2021) Per Borghammer et al. NEUROBIOLOGY OF DISEASE
- Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson’s Like Symptoms Without Loss of Dopaminergic Neurons
- (2021) Monika Sharma et al. NEUROTOXICITY RESEARCH
- Dietary Choline Protects Against Cognitive Decline After Surgery in Mice
- (2021) Sara V. Maurer et al. Frontiers in Cellular Neuroscience
- The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
- (2020) Lingyu Zhang et al. Journal of Parkinsons Disease
- Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model
- (2020) Tian Li et al. LIFE SCIENCES
- Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model
- (2020) Saumitra Sen Singh et al. Oxidative Medicine and Cellular Longevity
- Kaempferol in ameliorating diabetes-induced fibrosis and renal damage: An in vitro and in vivo study in diabetic nephropathy mice model
- (2020) Dilip Sharma et al. PHYTOMEDICINE
- Probiotic Clostridium Butyricum Ameliorated Motor Deficits in a Mouse Model of Parkinson's Disease via Gut Microbiota-GLP-1 Pathway
- (2020) Jing Sun et al. BRAIN BEHAVIOR AND IMMUNITY
- Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson’s disease
- (2020) Ariana Q. Farrand et al. Brain Stimulation
- Neuroprotective Effects of Coffee Bioactive Compounds: A Review
- (2020) Katarzyna Socała et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An outlook on the role of decaffeinated coffee in neurodegenerative diseases
- (2019) Raffaella Colombo et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson’s Disease
- (2019) Liping Zhang et al. Journal of Parkinsons Disease
- A Cleaning Crew: The Pursuit of Autophagy in Parkinson’s Disease
- (2019) Pathik Parekh et al. ACS Chemical Neuroscience
- Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson’s disease
- (2019) Abhijeet Parkhe et al. NEUROSCIENCE LETTERS
- Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
- (2018) Andre F. Batista et al. CNS DRUGS
- Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
- (2018) Run Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
- (2017) Yanwei Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Psoriasis and comorbid diseases
- (2017) Junko Takeshita et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- The role of polyunsaturated fatty acids and GPR40 receptor in brain
- (2017) Muhammad Zahid Khan et al. NEUROPHARMACOLOGY
- Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence
- (2017) Marta Guasch-Ferré et al. Oxidative Medicine and Cellular Longevity
- Stereological Estimation of Dopaminergic Neuron Number in the Mouse Substantia Nigra Using the Optical Fractionator and Standard Microscopy Equipment
- (2017) Chi Wang Ip et al. Jove-Journal of Visualized Experiments
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Delphinidin 3-rutinoside-rich blackcurrant extract ameliorates glucose tolerance by increasing the release of glucagon-like peptide-1 secretion
- (2017) Tsubasa Tani et al. Food Science & Nutrition
- Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors
- (2016) Ai-Jun Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
- (2016) Dilan Athauda et al. DRUG DISCOVERY TODAY
- Selective novel inverse agonists for human GPR43 augment GLP-1 secretion
- (2016) Bi-Oh Park et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
- (2016) Jaishree Jalewa et al. JOURNAL OF NEUROCHEMISTRY
- Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells
- (2016) Wassim Altarche-Xifro et al. EBioMedicine
- Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
- (2015) Maayan Levy et al. CELL
- Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain
- (2015) Simon C. Cork et al. Molecular Metabolism
- GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
- (2014) J J Credle et al. CELL DEATH AND DIFFERENTIATION
- Do GLP-1-Based Therapies Increase Cancer Risk?
- (2013) M. A. Nauck et al. DIABETES CARE
- Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain
- (2012) Stephen F.J. McGovern et al. BRAIN RESEARCH
- Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells
- (2012) Mari Teraoka et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-In Vitro
- (2012) Ganiyu Oboh et al. NEUROCHEMICAL RESEARCH
- Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity
- (2010) David Vauzour et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain
- (2009) Amit Khairnar et al. NEUROTOXICITY RESEARCH
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now